Form 8-K - Current report:
SEC Accession No. 0001558370-25-008613
Filing Date
2025-06-13
Accepted
2025-06-13 15:55:20
Documents
17
Period of Report
2025-06-11
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cyrx-20250611x8k.htm   iXBRL 8-K 49171
2 EX-99.1 cyrx-20250611xex99d1.htm EX-99.1 20433
3 EX-99.2 cyrx-20250611xex99d2.htm EX-99.2 602947
4 GRAPHIC cyrx-20250611x8k001.jpg GRAPHIC 8145
5 GRAPHIC cyrx-20250611xex99d1001.jpg GRAPHIC 11773
  Complete submission text file 0001558370-25-008613.txt   874794

Data Files

Seq Description Document Type Size
6 EX-101.SCH cyrx-20250611.xsd EX-101.SCH 3256
7 EX-101.LAB cyrx-20250611_lab.xml EX-101.LAB 18739
8 EX-101.PRE cyrx-20250611_pre.xml EX-101.PRE 13049
19 EXTRACTED XBRL INSTANCE DOCUMENT cyrx-20250611x8k_htm.xml XML 4834
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Filer) CIK: 0001124524 (see all company filings)

EIN.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34632 | Film No.: 251046255
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)